Episode

Why Exercise Still Matters in the GLP-1 Drug Era

Podcast: JAMA Medical News
Published: Jun 18, 2026
Duration seconds: 297
Processing state: not_requested
Canonical source: https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.10157
Audio: https://traffic.libsyn.com/secure/jamamedicalnews/Why_Exercise_Still_Matters_in_the_GLP-1_Drug_Era_2.mp3?dest-id=525944
JSON: /v1/public/podcasts/jama-medical-news-779603/episodes/why-exercise-still-matters-in-the-glp-1-drug-era
Markdown: /podcast/jama-medical-news-779603/why-exercise-still-matters-in-the-glp-1-drug-era.md

Actions

POST https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/why-exercise-still-matters-in-the-glp-1-drug-era/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/jama-medical-news-779603/why-exercise-still-matters-in-the-glp-1-drug-era.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA